A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations - Yamaura, T., Nakatani, T., Uda, K., Ogura, H., Shin, W., Kurokawa, N., Saito, K., Fujikawa, N., Date, T., Takasaki, M., Terada, D., Hirai, A., Akashi, A., Chen, F., Adachi, Y., Ishikawa, Y., Hayakawa, F., Hagiwara, S., Naoe, T., Kiyoi, H. (American Society of Hematology (ASH), 2018)
6146207